In 440 adults with anterior large-vessel occlusion stroke successfully reperfused after endovascular therapy, a reperfusion-guided systolic BP target vs guideline care (<180 mm Hg) raised 90-day mRS 0–2 (60.0% vs 47.1%); serious adverse events 15.8% vs 12.0%.
RCTn = 446
Camps-Renom et al. Personalized Blood Pressure Targeting After Endovascular Therapy for Acute Ischemic Stroke: A Randomized Clinical Trial